Generali Investments Cee, Investicni Spolecnost, A.S. Teva Pharmaceutical Industries LTD Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 20,400 shares of TEVA stock, worth $352,716. This represents 0.05% of its overall portfolio holdings.
Number of Shares
20,400Holding current value
$352,716% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
644Shares Held
587MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$743 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$674 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$627 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$499 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$470 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...